News

Before starting to prescribe stimulants to every adult who cannot concentrate, it is important to take a closer look at the research.

Should a patient at the end of her life have access to psilocybin, even if it’s illegal?

A new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.

The COVID-19 outbreak will eventually end, but public health experts expect this will not be the last pandemic. Will we have learned the right lessons so we can more successfully weather the next one?

Psilocybin may be useful for examining interactions between serotonin-dopamine systems and various psychiatric conditions, such as schizophrenia.

Every phase of the COVID-19 pandemic brings new ethical challenges.

A high-powered lawyer faces her toughest opponent yet: mental illness stigma.

The rise and fall of a brilliant medical pioneer.

During the pandemic, Albert Camus’ existential novels have become newly popular—and with good reason.

A study finds that testing genetic variations can predict outcomes and medication blood levels in patients with depression.

Catharsis expressed in a pen, it was a tool to get through the hard times, even medical school.

My life pasted on his wall to analyze, a flash of insight came to me: Training had begun.

The story of depression, through time and around the world.

The chief medical officer of Karuna shares his thoughts exclusively with Psychiatric Times.

Psychiatrists face diagnostic puzzles almost every day. Find out how one clinician cracked a tough case.

Many patients with bipolar and other psychiatric disorders believe it is better to wait to address cigarette and other nicotine use. Here is why that is not necessarily the case.

Join the conversation on Psychiatric Times

There are many reasons to look forward, armed with lessons learned and new research on the horizon.

The FDA has approved the New Drug Application for a once-daily ADHD treatment.

Providing quality mental health care in all treatment settings requires one crucial element: teamwork.

A case report and literature review of intrathecal methotrexate-induced mania.

If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.

How does relapse prevention for depression in patients with coronary heart disease differ from relapse prevention in those with depression alone? That question and more answered.

Some commonly used drugs and narcotics have serious cardiovascular effects.

As February comes to a close, we reflect on this month's contributions.

A new study considers how the virus might enter the brain and cause cognitive issues.

Black soldiers’ lack of access to opiate analgesics and antidiarrheals was typical, not exceptional, when considered within the broader scheme of Civil War medicine.

This comprehensive approach for assessing and addressing potential cardiac complications before prescribing psychotropics can enhance care.

A case for why psychiatrists should discuss the COVID vaccines with their patients.

When, where, and how to use poetry in a clinical setting.